Literature DB >> 7769141

Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity.

R V Considine1, E L Considine, C J Williams, M R Nyce, S A Magosin, T L Bauer, E L Rosato, J Colberg, J F Caro.   

Abstract

Obese (ob) gene expression in abdominal subcutaneous adipocytes from lean and obese humans was examined. The full coding region of the ob gene was isolated from a human adipocyte cDNA library. Translation of the insert confirmed the reported amino acid sequence. There was no difference in the sequence of an reverse transcription PCR product of the coding region from five lean and five obese subjects. The nonsense mutation in the ob mouse which results in the conversion of arginine 105 to a stop codon was not present in human obesity. In all 10 human cDNAs, arginine 105 was encoded by CGG, consequently two nucleotide substitutions would be required to result in a stop codon. To compare the amount of ob gene expression in lean and obese individuals, radiolabed primer was used in the PCR reaction with beta-actin as a control. There was 72% more ob gene expression (P < 0.01) in eight obese subjects (body mass index, BMI = 42.8 +/- 2.7) compared to eight lean controls (BMI = 22.4 +/- 0.8). Regression analysis indicated a positive correlation between BMI and the amount of ob message (P < 0.005). There was no difference in the amount of beta-actin expression in the two groups. These results provide evidence that ob gene expression is increased in human obesity; furthermore, the mutations present in the mouse ob gene were not detected in the human mRNA population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769141      PMCID: PMC295988          DOI: 10.1172/JCI118007

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

Review 1.  A molecular view of adipose tissue.

Authors:  G Ailhaud; P Grimaldi; R Négrel
Journal:  Int J Obes Relat Metab Disord       Date:  1992-12

Review 2.  Tackling a weighty problem.

Authors:  J M Friedman; R L Leibel
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 5.  Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice.

Authors:  D L Coleman
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

Review 6.  Genetic contributions to human obesity.

Authors:  A J Stunkard
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1991

7.  A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine.

Authors:  J W Kolaczynski; L M Morales; J H Moore; R V Considine; Z Pietrzkowski; P F Noto; J Colberg; J F Caro
Journal:  Int J Obes Relat Metab Disord       Date:  1994-03

Review 8.  The nutrient balance hypothesis: peptides, sympathetic activity, and food intake.

Authors:  G A Bray
Journal:  Ann N Y Acad Sci       Date:  1993-03-15       Impact factor: 5.691

Review 9.  Appetite and the regulation of body composition.

Authors:  D S Weigle
Journal:  FASEB J       Date:  1994-03-01       Impact factor: 5.191

10.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

View more
  60 in total

Review 1.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

2.  Contribution of androgens to the gender difference in leptin production in obese children and adolescents.

Authors:  M Wabitsch; W F Blum; R Muche; M Braun; F Hube; W Rascher; E Heinze; W Teller; H Hauner
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 3.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

4.  Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

Authors:  C B Kallen; M A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.

Authors:  D R Murdoch; E Rooney; H J Dargie; D Shapiro; J J Morton; J J McMurray
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

6.  Decreased food intake does not completely account for adiposity reduction after ob protein infusion.

Authors:  N Levin; C Nelson; A Gurney; R Vandlen; F de Sauvage
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 7.  Transcription, adipocyte differentiation, and obesity.

Authors:  J Auwerx; G Martin; M Guerre-Millo; B Staels
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

Review 8.  Hormone and glucose signalling in POMC and AgRP neurons.

Authors:  Bengt F Belgardt; Tomoo Okamura; Jens C Brüning
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

9.  Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents.

Authors:  M Igel; H Kainulainen; A Brauers; W Becker; L Herberg; H G Joost
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 10.  Leptin and obesity in humans.

Authors:  R V Considine
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.